Abaxis, Inc. (ABAX) reported that it has launched its first product, a rapid Avian Influenza Antigen Test, in the production animal diagnostics market. Avian Influenza Antigen Test is a disposable and USDA-licensed test for Avian Influenza Type A nucleoprotein antigen in chickens, turkeys and ducks. Abaxis has worldwide rights to market this product globally.
Avian Influenza Antigen Test is capable of providing results in fifteen minutes. It can be performed on-field or in a laboratory of any size.
Abaxis has a strong research and development team that evaluates various opportunities to leverage its intellectual property and other joint product development ventures. Including Avian Influenza Antigen Test, the company has launched four new products in different fields to date in 2009.
We think that the new product will boost Abaxis’ top-line. Abaxis is a manufacturer of portable medical (human) and veterinary (animal) blood analysis systems. It is the second largest and fastest growing animal health diagnostics company in the world. For medical use, the systems are marketed under the name Piccolo and measure metabolic, hepatic (liver), kidney, and renal (blood) function. Other uses include measuring electrolytes and cholesterol.
The systems used for veterinary (animal) use are marketed under the name VetScan and used under the following animal profiles: avian/reptilian, large animal, mammalian (liver) and equine (horse). Other uses include a comprehensive diagnostic profile, as well as a thyroxine/ cholesterol test.
Read the full analyst report on “ABAX”
Zacks Investment Research
